GIM
CELG

Groesbeck Investment Management’s Celgene Corp CELG Stock Holding History

Groesbeck Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,430
Closed -$440K – 107
2019
Q3 		$440K Buy
4,430
+180
+4% +$17.1K 0.33% 77
2019
Q2 		$393K Sell
4,250
-180
-4% -$17.1K 0.32% 78
2019
Q1 		$418K Hold
4,430
– – 0.32% 73
2018
Q4 		$284K Hold
4,430
– – 0.24% 78
2018
Q3 		$396K Hold
4,430
– – 0.27% 76
2018
Q2 		$352K Hold
4,430
– – 0.25% 77
2018
Q1 		$395K Hold
4,430
– – 0.29% 69
2017
Q4 		$462K Sell
4,430
-25
-0.6% -$2.82K 0.32% 70
2017
Q3 		$650K Hold
4,455
– – 0.47% 50
2017
Q2 		$579K Hold
4,455
– – 0.43% 51
2017
Q1 		$554K Buy
4,455
+150
+3% +$18K 0.41% 58
2016
Q4 		$498K Hold
4,305
– – 0.39% 62
2016
Q3 		$450K Sell
4,305
-425
-9% -$46K 0.33% 75
2016
Q2 		$467K Sell
4,730
-600
-11% -$62.1K 0.34% 61
2016
Q1 		$533K Hold
5,330
– – 0.38% 57
2015
Q4 		$638K Hold
5,330
– – 0.41% 58
2015
Q3 		$577K Hold
5,330
– – 0.36% 59
2015
Q2 		$617K Hold
5,330
– – 0.3% 64
2015
Q1 		$614K Hold
5,330
– – 0.3% 65
2014
Q4 		$596K Hold
5,330
– – 0.29% 67
2014
Q3 		$505K Hold
5,330
– – 0.24% 70
2014
Q2 		$458K Hold
5,330
– – 0.2% 71
2014
Q1 		$372K Buy
5,330
+350
+7% +$27.7K 0.17% 67
2013
Q4 		$421K Buy
4,980
+80
+2% +$6.33K 0.18% 63
2013
Q3 		$378K Buy
4,900
+100
+2% +$7.01K 0.16% 61
2013
Q2 		$281K Buy
+4,800
New +$289K 0.12% 62

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Groesbeck Investment Management's CELG Position: Q4 2019 in Review

Groesbeck Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,430 shares — an estimated $440K sold.

Groesbeck Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $650K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Groesbeck Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Groesbeck Investment Management sold 4,430 Celgene Corp shares in Q4 2019, an estimated $440K.
  • Groesbeck Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Groesbeck Investment Management's Celgene Corp position peaked at $650K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Groesbeck Investment Management's 13F filing for Q4 2019, filed 22 Jan 2020.